IN8BIO, INC. (INAB)
IN8BIO, INC. (INAB)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -5,090 | -4,942 | -3,854 | -10,644 |
| Depreciation and amortization | 245 | 245 | 244 | 511 |
| Non-cash stock-based compensation | 401 | 711 | 692 | 1,786 |
| Amortization of finance lease right-of-use assets | 108 | 119 | 126 | 526 |
| Amortization of operating lease right-of-use assets | 147 | 157 | 157 | 416 |
| Loss on disposal of construction in progress | NaN | 0 | 0 | NaN |
| Prepaid expenses and other current assets | -67 | -291 | 564 | -943 |
| Other non-current assets | -17 | -23 | -106 | 0 |
| Accounts payable | 140 | 105 | -175 | -10 |
| Accrued expenses and other current liabilities | -952 | 1,215 | -217 | -412 |
| Short-term operating lease liabilities | 206 | 186 | 201 | 225 |
| Long-term operating lease liabilities | -236 | -249 | -240 | -390 |
| Net cash used in operating activities | -4,947 | -2,139 | -3,524 | -7,049 |
| Purchases of property and equipment | 9 | 0 | 0 | 0 |
| Construction in progress | NaN | 0 | 0 | 0 |
| Net cash used in investing activities | -9 | 0 | 0 | 0 |
| Proceeds from the exercise of series c warrants, net of issuance costs-Series ABWarrants | NaN | NaN | 0 | 1,884 |
| Payment of issuance costs from december 2025 issuance of common stock | 88 | 0 | 0 | 0 |
| Proceeds from the issuance of common stock, net of issuance costs | 0 | 102 | 1,112 | 7,352 |
| Proceeds from the exercise of series a, b and c warrants, net of issuance costs | NaN | 2,264 | NaN | NaN |
| Proceeds from private placement common stock, net of issuance costs | NaN | 18,501 | NaN | NaN |
| Issuance of private placement common stock, net of issuance costs | NaN | 0 | NaN | NaN |
| Proceeds from the exercise of series c warrants, net of issuance costs | -383 | NaN | 0 | 383 |
| Principal payments on finance leases | 107 | 111 | 123 | 459 |
| Net cash (used in) provided by financing activities | -195 | 18,489 | 989 | 9,160 |
| Net (decrease) increase in cash and restricted cash | -5,151 | 16,350 | -2,535 | 2,111 |
| Cash and restricted cash at beginning of period | 27,312 | 10,962 | 11,386 | NaN |
| Cash and restricted cash at end of period | 22,161 | 27,312 | 10,962 | NaN |